293
Views
7
CrossRef citations to date
0
Altmetric
Research Articles

Protein content of antivenoms and relationship with their immunochemical reactivity and neutralization assays

, , , , , & show all
Pages 594-603 | Received 18 Jan 2014, Accepted 13 May 2014, Published online: 18 Jun 2014

References

  • Muñiz EG, María WS, Estevao-Costa MI, Buhrnheim P, Chávez-Olortegui C. Neutralizing potency of horse antibothropic Brazilian antivenoms against Bothrops snake venoms from the Amazonian rain forest. Toxicon 2000; 38:1859–1863.
  • Otero R, Nunez V, Osorio RG, Gutierrez JM, Giraldo CA, Posada CA. Ability of six Latin American antivenoms to neutralize the venom of Mapaná Equis (Bothrops atrox) from Antioquía and Chocó (Colombia). Toxicon 1995; 33:809–815.
  • Otero R, Núñez V, Gutierrez JM, Robles A, Estrada R, Osorio RG, et al. Neutralizing capacity of a new monovalent anti-Bothrops atrox antivenom: comparison with two commercial antivenoms. Braz J Med Res 1997; 30:375–379.
  • Saravia P, Rojas E, Escalante T, Arce V, Chavez E, Velasquez R, et al. The venom of Bothrosp asper from Guatemala: toxic activities and neutralization by antivenoms. Toxicon 2001; 39:401–405.
  • Theakston RD, Laing GD, Fielding CM, Lascano AF, Touzet JM, Vallejo F, et al. Treatment of snake bites by Bothrops species and Lachesis muta in Ecuador: laboratory screening of candidate antivenoms. Trans R Soc Trop Med Hyg 1995; 89:550–554.
  • World Health Organization. Normes relatives aux immunsèrums d'origine animale. W.H.O. Sér Rapp Tech 1969; 413:47–61.
  • World Health Organization. Progress in the Characterization of Venoms and Standarization of Antivenoms. Geneva: WHO Offset Publication; 1981.
  • World Health Organization. Guidelines for the Production, Control and Regulation of Snake Antivenoms Immunoglobulins. Geneva: WHO; 2010:134 pp.
  • Russell FE. Snake venoms immunology: Historical and practical considerations. J Toxicol Toxin Rev 1988; 7:1–82.
  • de Roodt AR, Dolab JA, Hajos SE, Fernández T, Segre L. Utilidad de los sueros terapéuticos de uso corriente en Argentina frente al envenenamiento por la serpiente Bothrops moojeni (“caisaca”) (Viperidae, Crotalinae. Medicina (Buenos Aires). 1997; 57:667–676.
  • de Roodt AR, Dolab JA, Fernández T, Segre L, Hajos SE. Cross reactivity and heterologous neutralization of crotaline antivenoms used in Argentina. Toxicon 1998; 36:1025–1038.
  • de Roodt AR, Dolab JA, Segre L, Simoncini C, Hajos SE, Fernández T, et al. The immunochemical reactivity and neutralizing capacity of polyvalent Vipera (European) antivenom on enzymatic and toxic activities in the venoms of crotalids from Argentina. J Venom Anim Toxins 1999a; 5:67–83.
  • de Roodt AR, Vidal JC, Litwin S, Dolab JA, Hajos SE, Segre L. Neutralización cruzada del veneno de Bothrops jararacussu por sueros antiofídicos heterólogos. Medicina (Buenos Aires). 1999b; 59:238–242.
  • Dias da Silva W, Guidolin R, Raw I, Higashi HG, Carcati CP, Morais JF, et al. Cross-reactivity of horse monovalent antivenoms to venoms of ten Bothrops species. Mem Inst Butantan 1989; 51: 153–168.
  • Mebs D, Polhmann S, Von Tenspolde W. Snake venoms hemorrhagins: Neutralization by commercial antivenoms. Toxicon 1988; 26:435–438.
  • Mebs D, Kornalik F. Studies on the cross-reactivity of snake venom antisera. Mem Inst Butantan 1989; 51:127–132.
  • Siles-Villarroel M, Rolim Rosa R, Zelante F, Guidolin R. Evidenciacao em camundongos da soroneutralizacao paraspecífica entre venenos e antivenenos botrópicos. Mem Inst Butantan 1978; 42/43:337–344.
  • Tan N-H, Choy S-K, Chin K-M, Ponnudaraig G. Cross-reactivity of monovalent and polyvalent Trimeresurus antivenoms with venoms from various species of Trimeresurus (Lance-headed viper) snake. Toxicon 1994; 32:849–853.
  • Wisiniewski MS, Hill RE, Havey JM, Bogdan GM, Dart RC. Australian Tiger Snake (Notechis scutatus) and Mexican coral Snake (Micrurus species) antivenoms prevent death from United States coral snake (Micrurus fulvius fulvius) venom in a mouse model. J Toxicol Clin Toxicol 2003; 41:1–70.
  • Dias da Silva W, Tambourgi DV. Comment on “Preclinical assessment of the neutralizing capacity of antivenoms produced in six Latin American countries against medically-relevant Bothrops snake venoms”. Toxicon 2011; 57:1109–1110.
  • Krifi MN, El–Ayeb M, Dellagi K. The improvement and standardization of antivenom production in developing countries: comparing antivenom quality. J Venom Anim Toxins 1999; 5:128–141.
  • Theakston RDG, Warrell DA, Griffiths E. Report of a WHO workshop on the standardization and control of antivenoms. Toxicon 2003; 41:541–557.
  • Ownby CL, Colberg TR. Comparisson of the immunogenicity and antigenicity composition of several venoms of snakes in the family Crotalidae. Toxicon 1990; 28:189–199.
  • Sánchez EE, Ramirez MS, Galan JA, Lopez G, Rodriguez-Acosta A, Perez JC. Cross reactivity of three antivenoms against North American snake venoms. Toxicon 2003a; 41:315–320.
  • Anderson SG, Gutierrez JM, Ownby CL. Comparison of the immunogenicity and antigenic composition of ten central American snake venoms. Toxicon 1993; 31:1051–1059.
  • Camey KU, Velarde DT, Sanchez EF. Pharmacological characterization and neutralization of the venoms used in the production of Bothropic antivenom in Brazil. Toxicon 2002; 40:501–509.
  • Moura Da Silva AM, D’Imperio Lima MR, Nishikawa AK, Brodskyn CI, Dos Santos MC, Furtado MFD, et al.Antigenic crossreactivity of venoms obtained from snakes of Genus Bothrops. Toxicon 1990; 28:181–188.
  • Siles-Villarroel M, Furlanetto RS, Rolim Rosa RS, Zelante F, Navas J. Contribucao ao estudo imunoquimico de venenos botropicos II. Analise comparativa dos componentes antigenicos comuns de seis especies de venenos botropicos. Mem Inst Butantan 1974a; 38:31–40.
  • Siles-Villarroel MS, Zelante F, Furlanetto RS, Rolim Rosa R. Contribucao ao estudo imunoquimico de venenos botropicos, I. Analise comparativa dos componentes antigenicos de seis especies de venenos frente a seus respectivos antivenenos, através das técnicas de dupla difusao e imunoelectroforese en gel de agar. Mem Inst Butantan 1974b;38:13–30.
  • Siles-Villarroel MS, Furlanetto RS, Rolim Rosa R, Zelante F, Navas J. Contribucao ao estudo imunoquimico de venenos botropicos III. Análise doscomponentes antigenicos comuns atraves da dupla difusao em gel de agar. Mem Inst Butantan 1976; 40/41:241–250.
  • Arce V, Rojas E, Ownby CL, Rojas G, Gutiérrez JM. Preclinical assessment of the ability of polyvalent (Crotalinae) and anticoral (Elapidae) antivenoms produced in Costa Rica to neutralize the venoms of North American snakes. Toxicon 2003; 41:851–860.
  • Rojas E, Quesada L, Arce V, Lomonte B, Rojas G, Gutierrez JM. Neutralization of four Peruvian Bothrops sp. snake venoms by polyvalent antivenoms produced in Peru and Costa Rica: preclinical assessment. Acta Trop 2005; 93:85–95.
  • Segura A, Castillo MC, Núñez V, Yarlequé A, Gonçalves LR, Villalta M, et al. Preclinical assessment of the neutralizing capacity of antivenoms produced in six Latin American countries against medically-relevant Bothrops snake venoms. Toxicon 2010; 56:980–989.
  • Laemmli UK. Cleavage of structural during the assembly of the head bacteriophage T4. Nature 1970; 227:680–685.
  • Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of protein from polyacrilamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979; 76:4350–4354.
  • Giallongo A, Kochoumian L, King TP. Enzyme and radioimmunoassays for specific murine IgE and IgG with different solid-phase immunosorbents. J Immunol Methods 1982; 52:379–393.
  • King TP, Joslyn A, Kochoumian MS. Antigenic cross-reactivity of venom proteins from hornets, wasps, and yellow jackets. J Allergy Clin Immunol 1985; 75:621–628.
  • Theakston RDG, Reid HA. Development of simple standard assay procedures for the characterization of snake venoms. Bull World Health Organ 1983; 61:949–956.
  • National Research Council, 2002. Guía para el cuidado y uso de los animales de laboratorio. Institute of Laboratory Animal Resources, Commission of Life Sciences (Copyright National Academy Press, Washington, D.C., 1996). Academia Nacional de Medicina, Eds. México DF. Available at: http://www.nal.usda.gov/awic/pubs/noawicpubs/careuse.htm [Accessed May 25, 2014].
  • Meier J, Theakston RDApproximate LD50 determinations of snake venoms using eight to ten experimental animals. Toxicon 1986; 24:395–401.
  • Ferreira ML, Moura da Silva AM, Franca FOS, Cardoso JL, Mota I. Toxic activities of venoms from nine Bothrops species and their correlation with lethality and necrosis. Toxicon 1992a; 30:1063–1068.
  • Kaiser E, Michl H. Chemistry and pharmacology of the venoms of Bothrops and Lachesis. In: E Buchler E Buckley eds. Venomous Animals and their Venoms. New York: Academic Press; 1971:307–317.
  • Squaiella-Baptistao CC, Marcelino JR, Ribeiro da Cunha LE, Gutiérrez JM, Tambourgi DV. Anticomplementary Activity of Horse IgG and F(ab’)2 antivenoms. Am J Trop Med Hyg 2014; 90:574–584.
  • Calvete JJ, Sanz L, Cid P, de la Torre P, Florez-Díaz M, Dos Santos MC, et al. Snake venomics of the Central American rattlesnake Crotalus simus and the South American Crotalus durissus complex points to neurotoxicity as an adaptive paedomorphic trend along Crotalus dispersal in South America. J Proteome Res 2010; 9:528–544.
  • Solano G, Segura A, Herrera M, Gómez A, Villata M, Gutiérrez JM, León G. Study of the design and analytical properties of the lethality neutralization assay used to estimate antivenom potency against Bothrops asper snake venom. Biologicals 2010; 38:577–585.
  • Leong PK, Tan NH, Fung SY, Sim SM. Cross neutralisation of Southeast Asian cobra and krait venoms by Indian polyvalent antivenoms. Trans R Soc Trop Med Hyg 2012; 106:731–737.
  • de Roodt AR. Estudio inmunobiológico del veneno de serpientes de importancia sanitaria de la Argentina. PhD thesis. Facultad de Farmacia y Bioquímica de la Universidad de Buenos Aires. 2002: 313 pp.
  • Ferreira ML, Moura da Silva AM, Mota I. Neutralization of different activities of venoms from nine species of Bothrops snakes by Bothrops jararaca antivenom. Toxicon 1992b; 30:1591–1602.
  • Bogarin G, Morais JF, Yamaguchi IK, Stephano MA, Marcelino JR, Nishikawa AK, et al. Neutralization of crotaline snake venoms from Central and South America by antivenoms produced in Brazil and Costa Rica. Toxicon 2000; 38:1429–1441.
  • Sanchez EE, Galán JA, Perez JC, Rodríguez-Acosta A, Chase PB, Pérez JC. The efficacy of two antivenoms against the venom of North American snakes. Toxicon 2003b; 41:315–320.
  • Smaligan R, Cole J, Brito N, Laing GD, Mertz BL, Manock S, et al. Crotaline snake bite in the Ecuadorian Amazon: randomized double blind comparative trial of three South American polyspecific antivenoms. BMJ 2004; 329:1129.
  • Schier JG, Wiener SW, Touger M, Nelson LS, Hoffman RS. Efficacy of Crotalidae polyvalent antivenin for the treatment of hognosed viper (Porthidiumnasutum) envenomation. Ann Emerg Med 2003; 41: 391–395.
  • Arni RK, Ward RJ.Phospholipase A2-A structural review. Toxicon 1996; 34:827–841.
  • Middlebrook JL. Cross-neutralization of phospholipase A2 neurotoxins from snake venoms. Toxicon 1991; 29:1481–1487.
  • Selistre De Araujo HS, White SP, Ownby CL. Sequence analysis of Lys49 phospholipase A2 myotoxins: a highly conserved class of proteins. Toxicon 1996; 34:1237–1242.
  • Yang CC. Structure-function relationship of phospholipase A2-from snake venoms. J Toxicol Toxins Rev 1994; 13:125–177.
  • Assakura MT, Reichl AP, Mandelbaum FR.Comparison of immunological, biochemical and biophysical properties of three hemorrhagic factors isolated from the venom of Bothrops jararaca. Toxicon 1986; 24:943–946.
  • Bjarnasson JB, Fox JW. Hemorrhagic metalloproteinases from snake venoms. Pharmac Ther. 1994; 62:325–372.
  • Markland FS. Snake venoms and the hemostatic system. Toxicon 1998; 36:1749–1800.
  • Claus I, Mebs D. Cross-neutralization of thrombin-like enzymes in snake venom by polyvalent antivenoms. Toxicon 1989; 27:1397–1399.
  • Harrison RA, Wuster W, Theakston RD. The conserved structure of snake venom toxins confers extensive immunological cross-reactivity to toxin-specific antibody. Toxicon 2003; 41:441–449.
  • Cruz NS, Alvarez RG. Rattlesnake bite complications in 19 children. Pediatr Emerg Care 1994; 10:30–33.
  • Offerman SR, Bush SP, Moynihan JA, Clarck RF. Crotaline Fab antivenom for the treatment of children with rattlesnake envenomation. Pediatrics 2002; 110:968–971.
  • Sotelo-Cruz N. Rattlesnake bite poisoning, health damage and treatment in children. Gac Med Mex 2003; 139:317–324.
  • Sotelo N. Review of treatment and complications in 79 children with rattlesnake bite. Clin Pediatr (Phila) 2008; 47:483–489.
  • García-Willis CE, Vela-Ortega R, Maya-Leal ME. Epidemiology of accidental snake poisoning in the pediatric population. Bol Med Hosp Infant Mex 2009; 66:36–40.
  • Jindal G, Manhajan V, Parmar VR. Antisnake venom in a neonate with snakebite. Indian Pediatr 2010; 47:349–350.
  • Leeprasert W, Kaojaren S. Specific antivenom for Bungarus candidus. J Med Assoc Thai 2007; 90:1467–1476.
  • Suravu K, Somavarapu V, Shastry AB, Kumar R. Clinical profile, species-specific severity grading and outcome determinants of snake envenomation: an Indian tertiary care hospital-based prospective study. Indian J Crit Care Med 2012; 14:187–192.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.